Differential regulation of Janus kinase 3 (JAK3) in bovine preovulatory follicles and identification of JAK3 interacting proteins in granulosa cells by unknown
RESEARCH Open Access
Differential regulation of Janus kinase 3
(JAK3) in bovine preovulatory follicles and
identification of JAK3 interacting proteins
in granulosa cells
Kalidou Ndiaye1,2*, Amélie Castonguay1, Gabriel Benoit1, David W. Silversides1 and Jacques G. Lussier1
Abstract
Background: Janus kinase 3 (JAK3) is a member of the membrane-associated non-receptor tyrosine kinase protein
family and is considered predominantly expressed in hematopoietic cells. We previously identified JAK3 as a
differentially expressed gene in granulosa cells (GC) of bovine preovulatory follicles. The present study aimed
to further investigate JAK3 regulation, to identify protein binding partners and better understand its mode of
action in bovine reproductive cells.
Results: GC were obtained from small follicles (SF), dominant follicles at day 5 of the estrous cycle (DF), and
ovulatory follicles, 24 h following hCG injection (OF). RT-PCR analyses showed greatest expression of JAK3 in
GC of DF, while JAK3 expression was downregulated in OF (P < 0.0001). In addition, there was a 5- and 20-fold
reduction of JAK3 steady-state mRNA levels in follicular walls, respectively at 12 and 24 hours post-hCG as compared
to 0 h (P < 0.05). Similarly, JAK3 expression was downregulated by the endogenous LH surge. These results were
confirmed in western blot analysis showing weakest JAK3 protein amounts in OF as compared to DF. Yeast two-
hybrid screening of a DF-cDNA library resulted in the identification of JAK3 partners in GC that were confirmed by
co-immunoprecipitation and included leptin receptor overlapping transcript-like 1 (LEPROTL1), inhibin beta A
(INHBA) and cyclin-dependent kinase inhibitor 1B (CDKN1B). In functional studies using bovine endometrial cells,
JAK3 increased phosphorylation of STAT3 and cell viability, while the addition of JANEX-1 inhibited JAK3 actions.
Conclusion: These results support a physiologically relevant role of JAK3 in follicular development and provide
insights into the mode of action and function of JAK3 in reproductive tissues.
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Background
Janus kinase 3 (JAK3) belongs to a family of membrane-
associated intracellular non-receptor tyrosine kinase
proteins that mediate signals initiated by cytokine and
growth factor receptors through the JAK/STAT pathway
[1, 2]. Other members of the Janus family include JAK1,
JAK2 and tyrosine kinase 2 (TYK2). In contrast to the
ubiquitous expression of JAK1, JAK2 and TYK2 [3, 4],
JAK3 is predominantly expressed in immune cells and is
involved in signal transduction by interleukin (IL) recep-
tors that share the common gamma chain (γc) of the
type I cytokine receptor family [5–8]. Non-receptor
tyrosine kinases are involved in diverse cellular processes
including proliferation, differentiation, cell migration and
survival [9–13]. In various systems, JAK signal transduc-
tion occurs via a well-characterized JAK/STAT pathway.
JAKs activate this pathway by binding to cytokine recep-
tors leading to the recruitment of STAT proteins, which
are then phosphorylated. After undergoing JAK-mediated
phosphorylation, the STAT transcription factors dimerize
* Correspondence: k.ndiaye@umontreal.ca
1Département de biomédecine vétérinaire, Faculté de médecine vétérinaire,
Centre de recherche en reproduction animale (CRRA), Université de
Montréal, P.O. Box 5000, St-Hyacinthe, Québec J2S 7C6, Canada
2Faculté de médecine vétérinaire, Département de biomédecine vétérinaire,
Université de Montréal, 3200 Rue Sicotte, St-Hyacinthe, Québec J2S 2M2,
Canada
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ndiaye et al. Journal of Ovarian Research  (2016) 9:71 
DOI 10.1186/s13048-016-0280-5
and translocate to the nucleus where they regulate the
transcription of specific genes [14, 15].
In mammals, the JAK/STAT pathway is the principal
signaling mechanism for a wide array of cytokines
and growth factors. Different JAKs and STATs are
recruited based on the specific tissue and the receptors
engaged in the signaling event [16]. Although the canon-
ical JAK/STAT pathway is simple and direct, the pathway
components can regulate or be regulated by members
of other signaling pathways, including those involving
the ERK MAP kinase, phosphatidylinositide 3-kinases
(PI3K), and receptor tyrosine kinase (RTK)/Ras/MAPK
pathways [17]. Effector proteins that contribute to JAK/
STAT events include the signal-transducing adapter
molecules (STAMs), which facilitate the transcriptional
activation of specific target genes, and the stat-interacting
proteins (StIP) that can associate with JAKs and
unphosphorylated STATs to facilitate JAK/STAT pathway
[18–20]. Conversely, the suppressors of cytokine signaling
(SOCS), the protein inhibitors of activated stats (PIAS)
and the protein tyrosine phosphatases (PTP) are major
negative regulators of the JAK/STAT pathway [21–23].
These data indicate that various proteins outside the
basic pathway machinery could influence the JAK/
STAT signaling.
JAK3 encodes for a 125-kDa protein made of seven
JAK homology (JH) domains. The carboxyl JH1 region
of JAK3 contains the activation loop, a region that
includes the tyrosine kinase catalytic domain [15]. The
kinase activity of JAK proteins depends on their phos-
phorylation at tyrosine residues in the activation loop of
the kinase domain. Multiple sites of autophosphorylation
have indeed been identified in this enzymatically active
JH1 domain [24–26]. The JH2 domain contains the
catalytically inactive pseudo-kinase domain, which is
tandemly linked to the N site of the JH1 domain and
represents a unique feature of JAK proteins in contrast
to other tyrosine kinases. Despite the lack of catalytic
activity, the pseudo-kinase domain is required for sup-
pression of basal activity of tyrosine kinases and for
cytokine-inducible activation of signal transduction [27].
The amino terminus region of JAK3 is composed of a
SH2-like domain (JH3 and JH4 domains) and a 4.1, ezrin,
radixin, moesin (FERM) homology domain (JH6 and JH7
domains). The FERM domain interacts with the kinase
domain, positively regulates the catalytic activity and is
critical for receptor binding, signal transduction and
maintenance of kinase integrity [28].
JAK3 is primarily expressed in hematopoietic cells
and the JAK/STAT pathway has been widely investigated
in immune cells, but JAK3 has also been found in a
wide range of tissues of both hematopoietic and non-
hematopoietic origin [29]. We previously identified JAK3
as a differentially expressed gene in granulosa cells of
bovine dominant follicles using a gene expression profiling
approach [30]. JAK3 was identified among a list of other
genes that were down-regulated in granulosa cells of
bovine ovulatory follicles following human chorionic
gonadotropin (hCG) injection as compared to growing
dominant preovulatory follicles during the estrous cycle. It
is well documented that the cyclic ovarian activity results
in profound modifications that require spatio-temporal
coordination of proliferation, apoptosis and differentiation
of various cell types within the follicle leading to changes
in gene expression. Of interest, granulosa cells play a
critical role in these reproductive functions as they
contribute to steroid hormone synthesis [31], oocyte
maturation [32], and corpus luteum formation after
ovulation [33]. Many factors such as follicle-stimulating
hormone receptor (FSHr) in small and growing follicles,
luteinizing hormone receptor (LHr) in ovulatory follicles,
steroid hormones (estradiol and progesterone) and growth
factors are produced by GC and affect follicular growth,
ovulation and differentiation into a functional corpus
luteum. Consequently, the regulation of granulosa cell
proliferation and function is complex and depends on the
precise regulation and activation of specific target genes.
This regulation is essential for normal follicular develop-
ment and timely production of paracrine factors as it
affects the physiological state of the dominant preovu-
latory follicle. For instance, the transcription of specific
genes that control the growth of a bovine dominant
preovulatory follicle is rapidly downregulated or silenced
in granulosa cells as a result of LH-mediated increases
in intracellular signaling [30]. These observations dem-
onstrate the critical importance of gene regulation
studies during the final stages of follicular develop-
ment as well as their interactions and mode of action.
In this regard, we identified JAK3 as a candidate gene
associated with follicular growth and dominance. We
report JAK3 differential regulation and binding part-
ners in bovine granulosa cells as well as its effects in
cell proliferation.
Results
JAK3 expression is differentially regulated during
follicular development
Expression of JAK3 is significantly reduced in ovulatory
follicles (OF) following hCG injection and in corpus
luteum (CL) as compared to dominant follicles (DF) at
day 5 of the estrous cycle (Fig. 1a; P < 0.0001). Additional
experiments showed a time-dependent reduction in
JAK3 mRNA expression following hCG injection with
the weakest expression observed after 24 h as compared
to 0 h (Fig. 1b; P < 0.001). The endogenous luteinizing
hormone (LH) surge model confirmed the downregu-
lation of JAK3 mRNA in the 24-h post-LH sample as
compared to 0 h (Fig. 1c). Western blot analysis using
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anti-JAK3 antibodies confirmed a downregulation of
JAK3 by hCG as the protein expression was significantly
stronger in DF as compared to OF (Fig. 1d).
Yeast two-hybrid screening revealed potential JAK3
partners in granulosa cells
The construct pGBKT7-JAK3 was not toxic to the
Y2HGold yeast strain and JAK3 did not, by itself,
activate the transcription of the reporter genes (AUR-C,
ADE2, HIS3, and MEL1), since no colonies grew when
Y2HGold[pGBKT7-JAK3] was plated in the presence of
aureobasidin A antibiotic (data not shown). To verify
that JAK3 protein was expressed in yeast cells, total pro-
teins from Y2HGold strain transformed with pGBKT7-
JAK3 was used to perform western blot analysis using
anti-c-Myc antibodies. The western blot analysis con-
firmed JAK3 expression in the Y2HGold yeast strain
(data not shown).
The mating of the Y2HGold[pGBKT7-JAK3] strain
with the Y187[pGADT7-cDNA] strain resulted in the
presence of zygotes that indicated a potential interaction
between the bait (JAK3) and prey proteins contained in
the granulosa cell library. Plasmids were purified from
positive yeast colonies, amplified by PCR and sequenced.
Sequence analyses resulted in different genes whose
protein products have potential interactions with JAK3,
including LEPROTL1, IHNBA and CDKN1B (Table 1).
JAK3 physically interacts with LEPROTL1, INHBA, and
CDKN1B
Physical interactions between JAK3 and candidate part-
ners were confirmed by in vitro co-immunoprecipitation
followed by western blot analyses and luminescence
measurements. JAK3 was cloned into pAcGFP1 vector
while LEPROTL1, INHBA and CDKN1B were cloned,
separately, into pProLabel vector. HEK 293 cells were
then co-transfected with pAcGFP1-JAK3 and pProLabel-
LEPROTL1, pProLabel-INHBA or pProLabel-CDKN1B.
Following each co-transfection, cells were collected,
proteins extracted and precipitated with anti-AcGFP
antibodies. The protein complexes were pulled down
using Protein G Plus/A Agarose Beads, subjected to
SDS-PAGE and western blotting using anti-LEPROTL1,
anti-INHBA or anti-CDKN1B. The results confirmed the
presence of LEPROTL1 migrating at 14 kDa (Fig. 2a),
INHBA at 44 kDa (Fig. 2b), and CDKN1B at 26 kDa
(Fig. 2c) as interacting partners of JAK3. Additionally,
relative luminescence was recorded as a result of ProLa-
bel activity following interactions between JAK3 and
LEPROTL1, INHBA or CDKN1B (Fig. 2d). Indeed,
after 25 min of addition of the substrate, there was a
42-fold, 34-fold and 15-fold induction in ProLabel
enzymatic activity in HEK cells co-transfected, respec-
tively, with JAK3 and LEPROTL1, JAK3 and INHBA or
JAK3 and CDKN1B as compared to the negative control
(Fig. 2d).
(See figure on previous page.)
Fig. 1 JAK3 mRNA expression and regulation in bovine follicles. Total RNA extracts of GC from small follicles (SF), dominant follicles (DF),
ovulatory follicles (OF), and corpus luteum at day 5 (CL) were analyzed by RT-PCR for JAK3 with GAPDH used as reference. a Gel analysis of JAK3 in
different groups of follicles and CL and corresponding histograms. JAK3 mRNA expression was strongest in DF and was significantly decreased in
OF and CL (P < 0.0001). b Gel analysis of JAK3 mRNA regulation in hCG-induced follicular walls (FW) isolated from OF at 0, 6, 12, 18 and 24 h (hrs)
after hCG injection and corresponding histograms. JAK3 mRNA was markedly decreased in FW 6 h post-hCG compared to its expression before
hCG treatment (P < 0.01) and reached its weakest expression 24 h post-hCG as compared to 0 h (P < 0.0001). c Gel analysis of JAK3 mRNA regulation
by endogenous LH. Similar to hCG, a decrease in JAK3 expression was observed 24 h after endogenous LH (LH) surge as compared to 0 h.
d Representative JAK3 protein expression and regulation in bovine follicles. Total protein extracts of GC from SF, DF, OF, and CL were analyzed by
western blot using anti-JAK3 antibodies. The strongest JAK3 protein expression was observed in the DF while weakest expression was observed in
OF reflecting the regulation of the mRNA. Data are presented as least-square means ± SEM, and the number of independent samples per group is
indicated in parenthesis
Table 1 List of confirmed JAK3 partners in granulosa cells
Genes Accession #a Freq. Ident. (%) E-value Description
INHBA NM_174363.2 4 100 0.0 B.T. Inhibin, beta A
LEPROTL1 BT025351.1 2 100 1e-101 B.T. Leptin receptor overlapping transcript-like 1
CDKN1B NM_001100346.1 3 99 3e-146 B.T. Cyclin-dependent kinase inhibitor 1B (p27, Kip1)
aAccession number of the best match found following nucleotide sequence comparison via BLAST search in GenBank.Freq., Frequency of cDNA clone
identification from yeast two-hybrid prey library; Ident. (%), Identity: represents homology estimates ofbovine prey cDNA fragments with nucleotide
sequences in GenBank database; B.T., Bos taurus
Sequences were analyzed for identity and resulted in candidate proteins potentially interacting with JAK3
Plasmids were purified from true positive yeast colonies, amplified by PCR and sequenced
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JAK3 partners are differently regulated during follicular
development
Total RNA extracts of GC from small follicles (SF),
dominant follicles (DF), ovulatory follicles (OF), and
corpus luteum at day 5 of the estrous cycle (CL) were
analyzed by RT-qPCR for LEPROTL1, INHBA and
CDKN1B expression using specific primers. There was
no significant difference in LEPROTL1 mRNA expres-
sion throughout follicular development from small to
ovulatory follicles (Fig. 3a), although LEPROTL1 expres-
sion significantly increased in the CL as compared to
SF. Expression of INHBA was significantly greater in
DF as compared to SF, OF and CL (Fig. 3b). For
CDKN1B, the steady-state mRNA level was greatest
in the CL as compared to granulosa cells of SF, DF
and OF, while there was no difference among the
different groups of follicles (Fig. 3c).
Protein expression was analyzed for these partners and
the results showed that LEPROTL1 protein expression
was strongest in DF, nearly absent in OF and weak in
the CL (Fig. 3d), despite the fact that there was no
significant variation in LEPROTL1 mRNA expression
among the different groups of follicles. This result
suggests a potential post-transcriptional regulation of
LEPROTL1 activity in granulosa cells. Similar to its
mRNA expression, INHBA protein was stronger in SF
and DF as compared to OF and CL (Fig. 3e), while
CDKN1B protein expression appeared strongest in the
CL, moderate in DF and weak in SF and OF (Fig. 3f ).
STAT proteins in granulosa cells
Western blot analyses using SF, DF, and OF samples
showed expression of STAT3 in GC throughout folli-
cular development (Fig. 4a). Although these analyses
were not quantitative, expression of STAT3 appeared
stronger in OF as compared to SF and DF. In contrast,
expression of phospho-STAT3 (pSTAT3) was stronger
in SF and DF as compared to OF (Fig. 4b). For STAT5,
both the non-phosphorylated (Fig. 4c) and the phosphory-
lated (Fig. 4d) forms are present in SF and DF with no
apparent differences between these two groups of follicles.
However, expression of STAT5 and pSTAT5 was weaker
in OF as compared to SF and DF (Fig. 4c and d).
JAK3 participates in the phosphorylation of STAT3 in
endometrial cells
Bovine endometrial cells were cultured and treated with
or without JANEX-1 and in the presence or absence of


















































Fig. 2 Confirmation of JAK3 interactions by co-immunoprecipitation, western blot analyses and luminescence measurement. LEPROTL1 (a), INHBA
(b) and CDKN1B (c) were confirmed as physically interacting with JAK3. D) Relative luminescence was recorded as a result of ProLabel activity
following interactions between JAK3 and LEPROTL1, INHBA and CDKN1B. There was a 42-fold, 34-fold and 15-fold induction in ProLabel enzymatic
activity in HEK cells co-transfected, respectively, with JAK3 and LEPROTL1, JAK3 and INHBA, and JAK3 and CDKN1B as compared to the negative
control. Exp. Ctl, experimental control; Pos. ctl, positive control; Neg. ctl, negative control
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JAK3. The addition of JANEX-1 reduced phosphory-
lation of STAT3 after 8 h of treatment and more so after
24 h (Fig. 5a). When cells were transfected with JAK3
prior to JANEX-1 treatment, the amount of pSTAT3
was stronger as compared to non-transfected cells
after 8 h post-JANEX-1 treatment (Fig. 5a, boxed lanes),
meaning that JAK3 increased STAT3 phosphorylation,
which was then reduced by JANEX-1 after 24 h (Fig. 5a).
Similarly, the addition of JANEX-1 reduced the amount of
phosphorylated STAT5 in endometrial cells not trans-
fected with JAK3 (Fig. 5b). The reduction of pSTAT5
amount was observed at 4 h post-JANEX-1 treatment,





























































































































Fig. 3 Regulation of JAK3 mRNA and protein partners during follicular development. Panels a), b), and c) Total RNA extracts of GC from
SF, DF, OF, and CL were used to analyze LEPROTL1, INHBA and CDKN1B expression by real time RT-qPCR with GAPDH as reference gene.
LEPROTL1 mRNA expression was significantly increased in the CL as compared to SF (a) while there were no differences among the SF,
DF and OF groups. Expression of INHBA was significantly greater in DF as compared to SF, OF and CL (b); expression of INHBA was also
greater in SF than in OF and CL (b). For CDKN1B, mRNA expression was significantly greater in the CL as compared to SF, DF and OF (c)
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and after 24 h, pSTAT5 was nearly extinct in the cells
(Fig. 5b). Surprisingly, overexpression of JAK3 by transfec-
tion in endometrial cells considerably reduced the amount
of phosphorylated STAT5 as compared to non-transfected
cells (Fig. 5b). The addition of JANEX-1 did not have any
effects on pSTAT5 amounts in JAK3-transfected cells.
JAK3 expression increased endometrial cell viability
To assess the role of JAK3 in cell viability, endometrial cells
were cultured and treated with or without JANEX-1, and in
the presence or absence of JAK3 overexpression. Cell viabil-
ity measurements showed a significantly higher proportion
of viable cells prior to treatments with JANEX-1 (Fig. 6). In
JAK3-non transfected cells, cell viability was significantly
reduced within 4 h of JANEX-1 treatment (P < 0.0002),
while in JAK3-transfected cells, a significant reduction in
cell viability was observed from 8 h post JANEX-1 treat-
ment (P < 0.0001). In the absence of JANEX-1, JAK3
significantly increased cell viability as compared to
non-transfected cells (Fig. 6, P < 0.0004).
Discussion
We report for the first time JAK3 regulation and protein
interactions in the reproductive system using granulosa
cells from ovarian follicles. We also demonstrated that
a functional JAK3 affects phosphorylation of STAT
proteins suggesting that JAK/STAT signaling is opera-
ting in these bovine reproductive cells. The major
findings of this study are that: 1) the greatest expression of
JAK3 is associated with the growing, estrogen-active fol-
licle; 2) JAK3 expression is hormonally-regulated as it is
significantly reduced by the endogenous LH surge and by
hCG injection in a time-dependent manner, and in the
corpus luteum after granulosa cells differentiation into
luteal cells; and 3) JAK3 phosphorylates STAT3 in endo-
metrial cells and increases cell viability since inhibition of
JAK3 with JANEX-1 significantly reduces both the phos-
phorylation of STAT3 and cell viability. These observa-
tions indicate that JAK3 is associated with increased cell
proliferation. It is known that JAK activation and the JAK/















Fig. 4 Expression of STAT3 and STAT5 proteins in granulosa cells during follicular development using samples from small (SF), dominant (DF), and
ovulatory (OF) follicles. pSTAT, phospho STAT. STAT3 was expressed throughout follicular development (panel a) while pSTAT3 expression was
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Fig. 5 Phosphorylation assays of STAT3 and STAT5 by JAK3 in endometrial cells. Endometrial cells were put into culture and transfected or
not with JAK3. Cells were then treated with 100 μM of JANEX-1 for 4, 8 and 24 h while control cells did not receive JANEX-1 treatment.
Cells were collected using the M-PER buffer and protein extracts were subjected to western blot analyses. A) JANEX-1 reduced the
phosphorylation of STAT3 after 8 h of treatment and more so after 24 h, while transfection with JAK3 prior to JANEX-1 treatment
increased the amount of pSTAT3. B) JANEX-1 reduced the amount of pSTAT5 in endometrial cells not transfected with JAK3 while
transfection with JAK3 considerably reduced the amount of pSTAT5 as compared to non-transfected cells
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migration and apoptosis depending on the signal, the tis-
sue, and the cellular context [10, 34, 35]. Because JAK3
expression in the OF and CL is considerably reduced com-
pared to the growing follicle, it is conceivable that JAK3
might be involved in granulosa cell proliferation rather
than in their differentiation.
Members of the JAK and STAT families constitute a
crucial signaling system that has been the focus of exten-
sive studies, notably in the function of immune cells.
JAK3 is primarly expressed in leukocytes and is required
for their development and function [36]. JAK3 typically
associates with the common γc subunit of cytokine
receptors, becomes activated following cytokine binding
to the receptor [6], and phosphorylates other proteins,
including STAT proteins, that mediate gene transcrip-
tion [37]. The range of proteins activated specifically by
JAK3 as well as the protein-protein interactions in which
JAK3 is involved could mediate different mechanisms in
various systems. JAK3 has been shown to phosphorylate
insulin receptor substrate-1 (IRS-1), IRS-2, PI3K/Akt
and focal adhesion kinase (FAK) [38], which contain
SH2 or other phospho-tyrosine-binding domains. Other
studies have used Drosophila to investigate the JAK/
STAT pathway in ovarian cell migration, sex determi-
nation and stem-cell maintenance [39, 40], and in
macrophages infected with F. tularensis, JAK3 is involved
in the phosphorylation of p38MAPK [41]. Herein, we
observed that JAK3 strongest expression was found in
the dominant follicle, which is active and growing while in
the ovulatory follicle, following the endogenous LH surge
or hCG injection, JAK3 expression was dramatically
reduced. These results suggest a specific role for JAK3 in
granulosa cells during follicular growth between the stages
of small antral follicles to preovulatory follicles, prior to
the LH surge, such as in granulosa cells proliferation
through the activation or inhibition of target proteins.
Using a yeast two-hybrid screening, we identified and
confirmed novel JAK3-interacting proteins in granulosa
cells that can act as downstream target proteins for
JAK3 signaling within the follicle. Some of these partners
are known to be expressed in dominant follicles and
participate actively in follicular development. Of interest,
we showed that inhibin beta A (INHBA) interacts with
JAK3 in granulosa cells of dominant follicles. Previous
spatiotemporal expression studies showed greatest mRNA
expression for INHBA in estrogen active follicles [42–44]
and an increase in activin-A protein secreted in follicular
fluid [45]. Activin promotes granulosa cells proliferation
and steroidogenesis and potentiates FSH actions on
granulosa cells by increasing FSH receptor expression
[46, 47], which underscores a key role for activin-A in
the dominant follicle’s development. Our data confirmed
expression of INHBA mRNA and protein in dominant
follicles in agreement with already published data. The
interaction between JAK3 and INHBA could increase
granulosa cells proliferation and participate in the growth
of the dominant follicle into the ovulatory stage, prior to
the LH surge.
In addition to INHBA, physical interactions were
confirmed by co-IP between JAK3 and potential partners
including LEPROTL1 and CDKN1B. Leptin receptor
overlapping transcript-like 1 (LEPROTL1), also referred
to as endospanin 2 [48], is a transmembrane protein
involved in the regulation of intracellular protein traffic-
king [49]. It belongs to the OB-RGRP/VPS55 family and
is widely expressed [50]. LEPROTL1 was isolated from a
human fetal brain cDNA library and was shown to
possess a JAK binding site (Pro(46)-Ile-Pro(48)) [50].
LEPROTL1 negatively regulates growth hormone (GH)
receptor cell surface expression in liver and may play a
role in liver resistance to GH during periods of reduced
nutrient availability [51]. Functionally, it has been shown
that transgenic mice overexpressing LEPROTL1 displayed
growth retardation and an impairment of GH-induced
STAT5 phosphorylation in the liver [51]. These studies
indicate that LEPROTL1 expression decreased GH signa-
ling while LEPROTL1 silencing increased GH signaling.
Furthermore, recent studies demonstrated that fibroblast
growth factor 21 (FGF21) inhibition of GH stimulatory
actions on IGF-1 expression in chondrocytes depends on
the intracellular activity of LEPROTL1 and LEPROT,
another member of the family [49]. Based on the available
data and our findings, one could assume that JAK3 bind-
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Fig. 6 Comparison of cell viability on cultured endometrial cells
treated with JANEX-1. In JAK3-non transfected cells, treatment with
JANEX-1 (100 μM) significantly reduced the number of viable cells
from 4 h through 24 h as compared to the control (P < 0.0002).
In JAK3-transfected cells, significant reduction of cell viability by
JANEX-1 was observed from 8 h after treatment (P < 0.0001). JAK3
overexpression in endometrial cells significantly increased cell viability
as compared to non-transfected cells (P < 0.0004). Means and
standard error of means (SEM) are shown
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process by reducing the potential negative feedback of
LEPROTL1 on the GH signaling and increasing IGF-1
availability in the growing follicle. In this regard, it has
been shown that GH increased IGF-1 secretion by ovine
granulosa cells in vitro [52] supporting the idea that an
increased GH signaling may regulate the ovarian function
through IGF-1 production by granulosa cells.
The third JAK3 partner that was confirmed by co-IP
was the cyclin-dependent kinase inhibitor 1B (CDKN1B
or p27(KIP1)). CDKN1B is a cyclin-dependent kinase
inhibitor that binds to and prevents the activation of
cyclin E-CDK2 or cyclin D-CDK4 complexes, and thus
controls the cell cycle progression at G1 [53, 54]. The
degradation of CDKN1B, which is triggered by its CDK-
dependent phosphorylation and subsequent ubiquitina-
tion, is required for the cellular transition from quiescence
to the proliferative state [55]. CDKN1B acts either as an
inhibitor or an activator of cyclin type D-CDK4 complexes
depending on its phosphorylation state and/or stoichio-
metry. The phosphorylation of CDKN1B occurs on serine,
threonine and tyrosine residues. Phosphorylation on
Ser-10 is the major site of phosphorylation in resting cells
and takes place at the G(0)-G(1) phase leading to protein
stability [56]. Phosphorylation on other sites is greatly
enhanced by mitogens, growth factors, cMYC and in
certain cancer cell lines [57, 58]. As a result, the phospho-
rylated CDKN1B form found in the cytoplasm is inactive.
Based on these reports, and in light of our current
findings, it may be possible that CDKN1B binding to
JAK3 leads to its phosphorylation and inactivation in
granulosa cells of dominant follicle, thus allowing the
progression of granulosa cell division and proliferation.
Indeed, the greatest expression of CDKN1B in the corpus
luteum suggests a role for CDKN1B in establishing
the nonproliferative state, which is required for differen-
tiation or for proper functioning of the differentiated
luteal cells. Our findings are consistent with previous
results showing that the luteinization process is associated
with up-regulation of CDKN1B (p27) that accumulated
during initial phases of luteinization and remained
elevated until termination of the luteal function [59].
Our data are also consistent with the report that, in
the bovine ovary, the expression of CDKN1B (p27)
mRNA was significantly reduced in granulosa cells
from oestrogen-active dominant follicles as compared
to oestrogen-inactive follicles [60], meaning that cyclins
and their inhibitors are associated with granulosa cell
proliferation at specific follicular developmental stages.
Because of the difficulty of obtaining and culturing
bovine primary granulosa cells from dominant follicles,
we used a bovine endometrial cell line to demonstrate
that JAK3 increased phosphorylation of STAT3 and that
addition of JANEX-1, a specific JAK3 inhibitor, reduced
the amount of JAK3-phosphorylated STAT3. These results
suggest that the phosphorylation of STAT3 is directly
linked to the presence of JAK3 in these cells. Moreover,
the presence of JAK3 was also associated with increased
cell viability since JANEX-1 significantly reduced the
proportion of viable cells while overexpression of JAK3
delayed the decrease in cell viability induced by JANEX-1.
Together, these data suggest the presence of a functional
JAK3 and possibly JAK/STAT pathway in endometrial
cells that may be involved in cell proliferation. During
follicular development, JAK3 is predominantly expressed
in the growing dominant follicle, suggesting that JAK3
may impact granulosa cell proliferation through the
phosphorylation of target proteins including STAT tran-
scription factors. We have shown that levels of phosphory-
lated STAT3 was stronger in small and dominant follicles
as compared to ovulatory follicles and even stronger in
small compared to dominant follicles. These observations
could mean that STAT3 phosphorylation by JAK3 in
granulosa cells may be associated with follicular growth.
However, it was recently proposed that the stronger
amount of pSTAT3 in small follicles was associated with
granulosa cells death and follicular atresia [61]. It would
be relevant to verify whether JAK3 increases STAT3
phosphorylation in bovine granulosa cells of atretic
small follicles as compared to healthy growing folli-
cles. Although we have demonstrated the presence of
pSTAT3 in granulosa cells and an increased STAT3
phosphorylation by JAK3 in endometrial cells, further
functional studies should clarify the roles of pSTAT3
in granulosa cell death in small follicles and in granulosa
cell proliferation in the growing dominant follicles follow-
ing a potential activation by JAK3. As for STAT5, surpri-
singly, JAK3 overexpression seemed to reduce the amount
of pSTAT5 in endometrial cells transfected with JAK3
although pSTAT5 is detected in non-transfected cells and
that JANEX-1 reduced pSTAT5 amounts. These findings
could mean that basal expression of JAK3 is required for
STAT5 phosphorylation while overexpression of JAK3
leads to the inhibition of STAT5 phosphorylation.
Conclusions
This study demonstrated that JAK3 is hormonally regu-
lated in bovine granulosa cells and identified partners to
JAK3 including LEPROTL1, INHBA and CDKN1B
whose binding to JAK3 may participate in follicular
growth through their activation or inhibition by JAK3.
Using a JAK3 inhibitor, we showed that JAK3 increased
phosphorylation of STAT3 but decreased phosphory-
lation of STAT5 and was associated with increased cell
viability. Together, these results support a role for JAK3
in follicular growth through increased cell viability and
kinase activity and contribute to expand our understan-
ding of the activity and control of the ovary.
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Methods
Cloning and characterization of JAK3
JAK3 was characterized from a differential hybridization
screening of a subtracted cDNA library using the sup-
pression subtractive hybridization approach [30]. We
established and analyzed a granulosa cell-cDNA library
from dominant preovulatory follicles and the cDNA
clone corresponding to JAK3 was identified as differen-
tially expressed in these follicles. JAK3 cDNA was ampli-
fied by PCR and entirely characterized by sequencing
before proceeding to subsequent experiments.
Experimental animal model and sample preparations
The regulation of JAK3 expression during follicular
development was studied using in vivomodels as previously
characterized [30]. Following estrous synchronization with
PGF2α, normal cycling crossbred heifers were randomly
assigned to a dominant follicle group (DF; n = 4), or an
ovulatory hCG-induced follicle group (OF; n = 4). In the DF
group, the ovary bearing the DF on the morning of day 5 of
the estrous cycle (day 0 = day of estrus) was obtained by
ovariectomy (via colpotomy). The DF was defined as
being > 8 mm in diameter and growing while subordinate
follicles were either static or regressing. The OF were
obtained following an injection of 25 mg of PGF2α on
day 7 to induce luteolysis, thereby promoting the develop-
ment of the DF of the first follicular wave into a preovu-
latory follicle. An ovulatory dose of hCG (3000 IU, iv;
APL, Ayerst Lab, Montréal, QC) was injected 36 h after
the induction of luteolysis, and ovaries bearing the
hCG-induced OF were collected by ovariectomy 24 h
post-hCG. Additional OF were collected at 0, 6, 12, 18,
and 24 h after hCG injection for follicular wall preparation
(n = 2 cows/time point). The sample at 0 h was repre-
sented by day 7 dominant follicle. Immediately following
ovariectomy, follicles were dissected into preparations of
follicular wall (theca interna with the attached granulosa
cells) [62] or further dissected into separate isolates of
granulosa cells [30], and stored at –70 °C. Additionally,
granulosa cells (GC) were collected from 2 to 4 mm small
follicles (SF) obtained from slaughterhouse ovaries, and a
total of three pools of twenty SF were prepared. Concen-
trations of progesterone (P4) and estradiol-17β (E2) as well
as their ratio (P4/E2) were validated by radioimmunoassay
of follicular fluid. Corpora lutea (CL) at day 5 of the
estrous cycle were obtained by ovariectomy and were
dissected from the ovarian stroma, frozen in liquid nitro-
gen, and stored at –70 °C. All animal procedures were
approved by the Animal Ethics Committee of the Faculty
of Veterinary Medicine of the University of Montreal.
mRNA expression analysis
Expression and regulation of JAK3 mRNA during
follicular development and following hCG injection was
analyzed by semi-quantitative RT-PCR. Total RNA was
extracted from bovine GC collected from follicles at
different developmental stages (SF, DF, OF) and CL,
and from the follicular walls (granulosa and theca cells)
collected at 0, 6, 12, 18, and 24 h post-hCG injection.
Specific JAK3 PCR primers (Table 2) were used and
the number of cycles was limited and optimized for
analysis of JAK3 mRNA expression. PCR reaction
products were separated on a 1.2 % TAE-agarose gel
with ethidium bromide, visualized by UV light, digitized
and analyzed by densitometry using ImageQuant software
(GE Healthcare Life Sciences). GAPDH was used as a
reference gene, and specific signals of JAK3 were norma-
lized with corresponding GAPDH signals.
Cell extracts and immunoblotting analysis
Granulosa cells and CL were obtained as described
above. Tissue samples were homogenized in T-PER
buffer (Pierce, Rockford, IL, USA) supplemented with
complete protease inhibitors (Roche Diagnostics, Laval,
QC, Canada), and centrifuged at 16,000 × g for 10 min
at 4 °C. The recovered supernatant was stored at −70 °C
until electrophoretic analyses were performed. For cell
cultures, the M-PER mammalian protein extraction
reagent (Pierce) was used. M-PER reagent was added to
the plates, cell debris was removed by centrifugation
(14,000 × g for 5 min at 4 °C) and the supernatants were
collected and stored at −70 °C until further analyses.
Total protein concentrations were determined using the
Bradford method [63] (Bio-Rad Protein Assay, Bio-Rad
Lab, Mississauga, ON, Canada) and immunoblotting was
performed as described previously [64]. Samples (50 μg
of proteins) were resolved by one-dimensional denatu-
ring 12 % Novex Tris-glycine gels (Invitrogen, Burlington,
ON, Canada) and transferred onto polyvinylidene difluoride
Table 2 Primers used in the expression analyses of Bos taurus
genes by PCR and RT-qPCR
Gene Primer sequence (5′–3′)a Accesion no. AS (bp)
GAPDH Fwd tgttccagtatgattccacccacg NM_001034034 703
Rv ggttgtctcctgcgacttcaacag
INHBA Fwd gctcatccctctcctttcact NM_174363 171
Rv cgatcatgttctggatgtcct
LEPROTL1 Fwd tactggcccctctttgttctg NM_001037462 207
Rv caagctccccactcgatcaaa
CDKN1B Fwd tgtcaaacgtgcgagtgtcta NM_001100346 150
Rv ctctgcagtgcttctccaagt
JAK3 Fwd gcacctccaagtgaggagac XM_010806603 729
Rv cctctcgaggtccatgatgt
Abbreviations: AS amplicon size (base pairs), Fwd forward primer, Rv,
reverse primer
aAll primers were designed and validated by the authors. Each primer was
used at a final concentration of 600 nM
Ndiaye et al. Journal of Ovarian Research  (2016) 9:71 Page 10 of 14
membranes (PVDF; GE Healthcare Life Sciences).
Membranes were incubated with specific first antibodies
against JAK3, STAT3, phospho-STAT3 (pSTAT3), STAT5,
and phospho-STAT5 (pSTAT5). All antibodies and
corresponding concentrations are listed in Table 3.
Immunoreactive proteins were visualized by incubation
with appropriate horseradish peroxidase-linked secondary
antibodies (1:10 000 dilution) followed by incubation
with the enhanced chemiluminescence system, ECL plus
(GE Healthcare Life Sciences) according to the manufac-
turer’s protocol and revelation using the ChemiDoc
XRS+ system (Bio-Rad).
Yeast two-hybrid procedure
JAK3 constructs for Y2H bait preparation
A detailed description of the yeast two-hybrid procedure
used in this study is provided in the Additional file 1.
Briefly, a JAK3 construct was generated by PCR amplifi-
cation of a 729 bp-fragment corresponding to the FERM
domain of JAK3 localized in the amino terminus region.
The PCR product was purified and cloned in frame
with the GAL4-DNA binding domain into the pGBKT7
vector to produce a bait plasmid using the Matchmaker
Gold Yeast Two-Hybrid System (Clontech) exactly as pro-
posed by the manufacturer. The bait plasmid (pGBKT7-
JAK3) was used to transform Y2HGold yeast strains
using the Yeast Transformation system 2 kit (Clontech)
and this bait was referred to as Y2HGold[pGBKT7-JAK3].
Y2HGold yeast cells harbor four reporter genes (HIS3,
ADE2, MEL1 and AUR1) under the control of GAL4
upstream activating sequences, which are used to detect
two-hybrid interactions. To determine whether JAK3
protein was expressed, c-Myc monoclonal antibody was
used in western blot analysis to detect JAK3 protein in
yeast cells containing pGBKT7-JAK3 constructs. To
confirm that the pGBKT7-JAK3 bait did not autono-
mously activate the reporter genes in Y2HGold in the
absence of a prey protein, competent Y2HGold cells were
transformed with pGBKT7-JAK3 and the transformant
were plated on appropriate selective agar plates (See
Additional file 1). In parallel, competent Y2HGold cells
were transformed with pGBKT7 empty vector (pGBKT7)
along with pGBKT7-JAK3 to verify toxicity of the
JAK3 bait protein when expressed in yeast cells. All plated
yeast cells were incubated at 30 °C for 5 days.
Generation of granulosa cells (GC)-cDNA library and
construction of the two-hybrid prey library
A bovine GC-cDNA prey library from dominant follicles
was prepared in the Y187 yeast strain using the pGADT7-
Rec vector. cDNAs were expressed and fused to the GAL4
activating domain using the Matchmaker library construc-
tion & screening kit (Clontech) as detailed by the manu-
facturer. Total RNA was isolated from GC of dominant
follicles and used to generate cDNAs. Oligo dT (CDSIII)-
primed cDNAs were generated using the Make Your
Own “Mate & Plate” Library System (Clontech) with 1 μg
of bovine GC RNA. Long distance PCR (LD-PCR) was
performed using the Advantage 2 Polymerase Mix, PCR
products were purified (size-selected) using CHROMA
SPIN + TE-400 columns (Clontech), and the resulting
cDNAs were analyzed on a 1 % agarose gel. To create the
prey library, competent Y187 yeast cells were prepared
and co-transformed with 3 μg of dominant follicle
GC-cDNAs and the pGADT7-Rec plasmid (0.5 μg/μl).
The co-transformed yeast cells were spread on 150 mm
selective agar plates. After 5 days of incubation at 30 °C,
the 150 mm plates were chilled at 4 °C for 3 h and
5 ml of freezing medium was added to each plate to
harvest and pool all transformants. Cell density was
estimated using a hemocytometer and the library was
frozen at −70 °C. This library was referred to as
Y187[pGADT7-cDNA].
Screening of the two-hybrid library using yeast mating
A detailed description of the screening procedure is
provided in the Additional file 1. Briefly, Y2HGold
yeast cells carrying the bait plasmids (Y2HGold[pGBKT7-
Table 3 Antibodies used in the expression analyses of Bos taurus proteins by Western blot
Target proteins Antibodies Sources MW (kDa) Conc.
Beta Actin Chicken IgY anti-Beta actin antibody Immune Biosolutions (Cat. # Y00005-002) 42 —
JAK3 Goat polyclonal anti-JAK3 Santa Cruz Biotechnology (Cat. # sc-1080) 125 0.4 μg/ml
STAT3 Rabbit monoclonal anti-STAT3 Abcam (Cat. # ab32500) 92 0.069 μg/ml
pSTAT3 Rabbit monoclonal anti-pSTAT3 Abcam (Cat. # ab32143) 98 1 μg/ml
STAT5 Rabbit polyclonal anti-STAT5 Abcam (Cat. # ab68465) 90 0.5 μg/ml
pSTAT5 Rabbit polyclonal anti-pSTAT5 Abcam (Cat. # ab97734) 90 1 μg/ml
LEPROTL1 Rabbit polyclonal anti-LEPROTL1 Abcam (Cat. # ab139564) 14 1 μg/ml
INHBA Rabbit polyclonal anti-INHBA Aviva Systems Biology (# ARP54663_P050) 44 0.5 μg/ml
CDKN1B Goat polyclonal anti-CDKN1B/KIP1 Aviva Systems Biology (# OAEB01630) 26 0.1 μg/ml
Abbreviations: pSTAT, phospho STAT, MW molecular weight of target proteins analyzed, Conc., antibody concentrations used for immunoblotting
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JAK3]) were mated with Y187 yeast cells harboring the
bovine GC-cDNA library (Y187[pGADT7-GC]). Only
library plasmids responsible for the activation of all four
reporter genes were rescued and isolated using the Easy
yeast plasmid isolation kit (Clontech). To generate
sufficient plasmid to allow their characterization by
sequencing, prey plasmids were used to transform Stellar
competent bacteria that were plated on LB agar plates
with 100 μg/ml of ampicillin. The prey inserts were iden-
tified by sequencing and nucleic acid sequences were
verified for the presence of an open reading frame fused
in frame to the GAL4 AD sequence. Prey insert sequences
were compared to GenBank sequences via BLAST analysis
to determine their identities.
Co-IP confirmation of protein interactions
Physical interaction between JAK3 and candidate partners
was confirmed by in vitro co-immunoprecipitation assay
using the Matchmaker Co-IP system (Clontech). The
JAK3 bait was cloned into the linearized pAcGFP1-C
vector and its potential prey partners from the GC-cDNA
library were cloned into the linearized pProLabel-C vector
using the In-fusion HD EcoDry cloning kit (Clontech).
The two plasmid constructs were used to co-transfect
HEK 293 cells using the CalPhos Mammalian transfection
kit (Clontech) as recommended by the manufacturer.
Fourthy-eight hours post-transfection, cells were collected
and cell lysates were prepared for the co-IP assay. Each
lysate sample was incubated with 1 μl of the anti-AcGFP
polyclonal antibody on a rotator at 4 °C for 2 h. After the
antibody incubation, the entire volume of each sample
was transferred to a tube containing washed Protein G
Plus/Protein A Agarose Beads and incubated overnight at
4 °C with gentle rotation. Beads were thereafter gently
pelleted by centrifugation at 4 °C, 5000 × g for 10 s
followed by washing. The samples were subjected to
SDS-PAGE analysis and blotted with specific prey anti-
bodies to confirm the presence of prey proteins physically
interacting with JAK3 using specific antibodies (Table 3).
The selected preys were leptin receptor overlapping
transcript-like 1 (LEPROTL1), inhibin beta A (INHBA),
and cyclin-dependent kinase inhibitor 1B (CDKN1B)
based on the number of times they were identified and
their potential (for LEPROTL1 and CDKN1B) or known
(INHBA) roles in the ovary. In addition, the luminescence
generated as ProLabel enzymatic activity was measured
in protein samples from cells co-transfected with
pAcGFP1-JAK3 and separate prey partners along with
appropriate controls using the ProLabel detection kit
(Clontech) following the manufacturer’s protocol.
Regulation of JAK3 partners during follicular development
The regulation of JAK3 partners expression were analyzed
during follicular development at the mRNA and protein
levels using, respectively, RNA samples from SF, DF, OF
and CL, and protein samples from granulosa cells of SF, DF
and OF as described above. Expression of mRNA for
INHBA, LEPROTL1, and CDKN1B was quantified by real
time RT-qPCR using specific primers (Table 2) and the re-
sults were analyzed using the Livak method (2-ΔΔCq) [65].
Protein expression for INHBA, LEPROTL1 and CDKN1B
was analyzed using corresponding antibodies (Table 3).
JAK3 functional studies
To further study JAK3 function and determine whether
its activity is necessary for the phosphorylation of target
proteins, a bovine endometrial cell line (Endo 8.3) [66]
were cultured and treated with or without JANEX-1, a
JAK3 inhibitor [67], to verify for JAK3-phosphorylated
STAT proteins. Endometrial cells were first transfected,
or not, with the entire JAK3 open reading frame cloned
into the pAcGFP1 vector using the CalPhos transfection
kit (Clontech). JANEX-1 treatment (100 μM) was then
added 16 h after JAK3 transfection. Whole cell lysates were
collected at different time points after JANEX-1 treatment
and subjected to western blot analysis to verify phosphoryl-
ation of STAT3 and STAT5 using, respectively, anti-
phospho STAT3 and anti-phospho STAT5 antibodies. In
addition, to determine cell viability using the CellTiter assay
kit (Promega), endometrial cells were seeded on 96-well
plates and incubated at 37 °C/5 % CO2 in DMEM supple-
mented with 10 % fetal bovine serum. After incubation with
or without JANEX-1, the CellTiter substrate was added for
3 h before measuring absorbance at 490 nm with the
SpectraMax i3 (Molecular Devices).
Statistical analyses
Values for JAK3 and other target gene mRNAs were
normalized with those of the control gene GAPDH.
Homogeneity of variance between groups was verified
by O’Brien and Brown-Forsythe tests. Corrected values
of gene specific mRNA levels were compared between
follicular or CL groups by one-way ANOVA. When
ANOVA indicated a significant difference (P < 0.05), the
Tukey-Kramer test was used for multiple comparison of
individual means among SF, DF, OF and CL, whereas the
Dunnett test (P < 0.05) was used to compare different time
points after hCG with 0 h as control. These statistical
analyses were performed using JMP software (SAS Institute,
Inc.). Statistical analyses for proliferation assays were
performed using Prism software 6.0 for Macintosh (Graph-
Pad). All data were presented as least-square means ± SEM.
Additional file
Additional file 1: Detailed description of the Yeast two-hybrid procedure.
(DOCX 114 kb)
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